Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
43,056,667
-
Total 13F shares
-
27,148,766
-
Share change
-
+889,562
-
Total reported value
-
$931,197,865
-
Price per share
-
$34.30
-
Number of holders
-
61
-
Value change
-
+$31,433,436
-
Number of buys
-
37
-
Number of sells
-
16
Institutional Holders of Repare Therapeutics Inc. - Common Shares, no par value (RPTX) as of Q4 2020
As of 31 Dec 2020 Repare Therapeutics Inc. - Common Shares, no par value (RPTX) had 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 27,148,766 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, MPM ASSET MANAGEMENT LLC, BVF INC/IL, FMR LLC, Redmile Group, LLC, CHI Advisors LLC, MPM ONCOLOGY IMPACT MANAGEMENT, L.P., MPM Oncology Impact Management LP, Logos Global Management LP, and ARK Investment Management LLC.
This table shows 61 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.